Alsup Laurie Smaldone serves as Executive at Theravance Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Alsup Laurie Smaldone has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 29, 2024 involved receiving (via award) 5,899 shares valued at $0.
Alsup Laurie Smaldone currently holds 10,020 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alsup Laurie Smaldone has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Alsup Laurie Smaldone's most recent insider trade was on May 29, 2024, when they sold 5,899 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 15, 2023 | ARVN | $0 | Award | 4,121 | $N/A | Discretionary |
| May 2, 2023 | TBPH | $0 | Award | 9,132 | $N/A | Discretionary |
| Apr 26, 2022 | TBPH | $0 | Award | 9,852 | $N/A | Discretionary |
| Apr 27, 2021 | TBPH | $0 | Award | 9,828 | $N/A | Discretionary |
| Apr 28, 2020 | TBPH | $0 | Award | 6,635 | $N/A | Discretionary |
| Apr 30, 2019 | TBPH | $0 | Award | 8,385 | $N/A | Discretionary |
| May 1, 2018 | TBPH | $0 | Award | 8,186 | $N/A | Discretionary |
| Feb 13, 2018 | TBPH | $0 | Award | 1,776 | $N/A | Discretionary |